R&G PharmaStudies Co., Ltd. approved the cash dividend of CNY 2.50 (tax included) per 10 shares for the year 2022, at the AGM held on May 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.43 CNY | +1.08% |
|
-3.27% | -40.40% |
06-03 | R&G PharmaStudies Co., Ltd. Approves the Election of Directors | CI |
06-03 | R&G PharmaStudies Co., Ltd. Approves Cash Dividend for 2023 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.40% | 508M | |
-22.28% | 77.04B | |
+3.24% | 26.87B | |
-9.70% | 17.3B | |
0.00% | 16.89B | |
+0.78% | 15.44B | |
-23.68% | 13.16B | |
+70.99% | 13.15B | |
+77.65% | 13.11B | |
+24.05% | 12.66B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Approves the Cash Dividend for the Year 2022